Demand and Trend Analysis of Calcium Supplement in Japan

A Complete Study of Calcium Supplement in Japan from 2023 to 2033

The calcium supplement industry in Japan is expected to develop at a CAGR of 10.0% through 2033. The demand for calcium supplement in Japan is expected to grow significantly, reaching USD 153.3 million in 2023.

The contemporary generation's holistic attitude to health and well-being has spurred solutions that address issues ranging from dietary inadequacies to lifestyle disorders. Therefore, the calcium supplement industry in Japan is anticipated to be worth USD 395.8 million by 2033.

Key Highlights:

• People are suffering from various lifestyle ailments due to growing urbanization and, as a result, a rise in sedentary lifestyles. This has resulted in many individuals suffering from dietary deficiencies, particularly calcium inadequacy, with women being the most affected. As a result of this circumstance, sales of calcium supplements have increased, and consumers have begun to consume more of them.
• Calcium insufficiency is a prevalent problem among older people. Bone problems such as osteoporosis grow more frequent as people age. Health specialists recommend calcium supplements to safeguard their bone health. As a result of individuals' rising need for calcium supplements, the industry has grown considerably in Japan.

Attributes	Key Statistics
Expected Base Year Value (2023)	USD 153.3 million
Anticipated Forecast Value (2033)	USD 395.8 million
Estimated Growth (2023 to 2033)	10.0% CAGR

Consumption Analysis of Calcium Supplement in Japan

• Health supplement companies now have the chance to reach a larger audience and increase their online presence, owing to the trend toward eCommerce. Furthermore, there is an increased emphasis on wellbeing and self-care. In uncertain times, many resorted to supplements as a self-care strategy to keep things regular.
• Supplements containing calcium, particularly, are becoming increasingly well-liked as a convenient option for keeping strong bones. At present, individuals learn more about the science underlying the body's need for calcium and its potential advantages in maintaining the health of the heart, muscles, and neurons. As a result, the use of calcium supplement in Japan is anticipated to increase in the coming years.
• As the demand for cruelty-free products rises, people started shifting from animal-based proteins to plant-based supplement items. Moreover, the body digests and absorbs vitamins and minerals from plants far more efficiently than synthetic sources.
• Manufacturers are increasingly focusing to innovative technologies that offer targeted products domestically. Consequently, a growing number of people are using herbal remedies and supplements. Additionally, businesses are drawn to providing clean-label products to cater to their clientele's changing preferences.

Category-wise Insights

Soft Gel Pills are the Next Big Thing in Japan’s Calcium Supplement Industry

Attributes	Details
Form	Soft Gel Pills
Industry Share in 2023	49.8%

• The soft gel pill segment is anticipated to expand considerably, accounting for 49.8% of the total in 2023. Due to their easy swallowing and suitability for oil- and fat-soluble formulations, soft gel tablets now dominate the industry share.
• People with dietary restrictions now have additional options for vitamins, minerals, and supplements, owing to the addition of carrageenan in vegetarian and vegan encapsulations.
• Soft gel pills are easier to carry and swallow, making them the perfect choice to dominate the landscape of calcium supplement in Japan.

Male Population Primarily Propels the Demand Calcium Supplement in Japan

Attributes	Details
End Use	Men
Industry Share in 2023	39.5%

• Men's supplement consumption is predicted to capture a 39.5% industry share in 2023.
• Sales of calcium supplement in Japan are predicted to grow significantly due to men's growing health consciousness and gym lifestyle.
• One of the important target markets for producers of supplements for bone and joint health is the male population.
• Since these supplements target a specific area of the body and provide health advantages, customers are willing to pay a premium for them to maintain a healthy lifestyle and prevent age-related bone problems, especially in later life.

Competitive Landscape

The competitive landscape of the calcium supplement industry in Japan is quickly expanding, owing to an aging population, increased health consciousness, and a growing desire for self-care.

Leading companies in the Japan calcium supplement industry include Eisai, Morinaga Milk Industry, UNIMAT RIKEN, ORIHIRO, Asahi Group, Otsuka, DHC, Bean Stalk Snow, Dainippon Pharmaceutical, and Kobayashi Pharmaceutical.

These firms offer a wide range of calcium supplements, catering to various customer sectors and demands. The industry in Japan is predicted to experience further growth in the future years. New product innovations, such as calcium supplements with additional nutrients or functional components, are also anticipated to impact the industry.

Recent Developments in the Calcium Supplement Industry in Japan

• Kyowa Hakko Bio Co., Ltd. developed a novel probiotic strain in June 2023 that has been demonstrated in animal trials to increase calcium absorption.
• Suntory Beverage & Food Limited introduced "Calcium Water," a calcium-fortified mineral water with 300mg of calcium per bottle, in February 2023.
• Rohto Pharmaceutical Co., Ltd. developed a novel calcium supplement formulation in October 2022 that incorporates nano-sized calcium particles for improved absorption.
• Daiwa Pharmaceutical Co., Ltd. introduced a new calcium supplement named "Boneplus" in April 2022, which incorporates vitamin D3, vitamin K2, and magnesium in addition to calcium.

Key Players Offering Calcium Supplement in Japan

• Eisai Company, Ltd.
• Morinaga Milk Industry
• Dainippon Pharmaceutical
• Kobayashi Pharmaceutical
• Rohto Pharmaceutical Co.
• Daiwa Pharmaceutical Co.
• Kyowa Hakko Bio Co., Ltd.
• Suntory Beverage & Food Limited
• UNIMAT RIKEN
• ORIHIRO
• Asahi Group
• Otsuka
• DHC
• Bean Stalk Snow

Scope of the Report

Attribute	Details
Estimated Valuation (2023)	USD 153.3 million
Projected Valuation (2033)	USD 395.8 million
Anticipated CAGR (2023 to 2033)	10.0% CAGR
Historical Analysis of Calcium Supplement in Japan	2018 to 2022
Demand Forecast for Calcium Supplement in Japan	2023 to 2033
Quantitative Units	Revenue in USD million and CAGR from 2023 to 2033
Report Coverage	Industry Size, Industry Trends, Key Insights for Calcium supplement Adoption in Japan, Insights on Global Players and Leading Industry Strategy in Japan, Ecosystem Analysis of Local and Regional Industry.
Key Companies Profiled	Eisai Company, Ltd.; Morinaga Milk Industry; Dainippon Pharmaceutical; Kobayashi Pharmaceutical; Rohto Pharmaceutical Co.; Daiwa Pharmaceutical Co.; Kyowa Hakko Bio Co., Ltd.; Suntory Beverage & Food Limited; UNIMAT RIKEN; ORIHIRO; Asahi Group; Otsuka; DHC; Bean Stalk Snow

Key Segments

By Form:

• Tablets
• Capsule
• Powder
• Soft Gel Pills
• Liquid
• Others

By End Use:

• Men
• Women
• Children
• Infants

By Type:

• Child calcium supplement
• Adult calcium supplement

By Application:

• Online
• Offline

By City:

• Kanto
• Chubu
• Kinki
• Kyushu & Okinawa
• Tohoku
• Rest of Japan

Frequently Asked Questions

At What Rate is the Calcium Supplement Industry Growing in Japan?

The anticipated CAGR for the Japan calcium supplement industry through 2033 is 10.0%.

How Big will the Calcium Supplement Landscape be in Japan?

Demand for calcium supplement in Japan is likely to surpass USD 395.8 million by 2033.

What is the Current Industry Size of Calcium Supplement in Japan?

In 2023, the industry size of the calcium supplement in Japan is anticipated to be USD 153.3 million.

Which is the Preferred Form of Calcium Supplement in Japan?

Soft gel pills are the preferred form of calcium supplement in Japan, with an industry share of 49.8%.

Which is the Common End User of Calcium Supplement in Japan?

In Japan, male population dominates the calcium supplement industry, with a share of 39.5%.